跳至主要内容
临床试验/ISRCTN21996121
ISRCTN21996121已完成不适用

Impact of In-exsufflator Treatment on hospitalisation for Respiratory Exacerbation in Neuromuscular Disease

Children's Hospital of Eastern Ontario (Canada)0 个研究点目标入组 128 人开始时间: 2007年9月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
128

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients aged 3 to 17 years
  • 2. Patients have a known neuromotor disorder affecting respiratory muscles
  • 3. Admitted to hospital with a respiratory deterioration (hypoxemia in the presence of new onset radiologically proven atelectasis or consolidation)

排除标准

  • 1. Refusal to participate
  • 2. Already using the Emerson in-exsufflator at home on a regular basis
  • 3. Development of new uncompensated hypercapnic respiratory failure requiring intubation and mechanical ventilation
  • 4. History of bullous emphysema, known susceptibility to pneumothorax or pneumomediastinum, or known to have had any recent barotraumas

研究者

发起方
Children's Hospital of Eastern Ontario (Canada)

相似试验